Birmingham secures $44 million in federal Tech Hub grants

Birmingham’s biotech future: How a $44M AI grant could transform the industry
The Birmingham Biotechnology Hub will receive funding to use artificial intelligence to shorten drug development to provide affordable drugs, vaccines and diagnostics.
Birmingham Biotechnology Hub awarded $44 million grant for AI-driven projects
U.S. Rep. Terri Sewell announced that the U.S. Department of Commerce’s Economic Development Administration has awarded a $44 million grant to the Birmingham Bi
$44 million in grants awarded to Birmingham Biotechnology Hub
The Economic Development Administration announced it will award Birmingham Biotechnology Hub $44 million in grants. The hub is led by the Southern Research Institute. The $44 million will implement five projects.
Birmingham Biotech Hub Receives $44M Federal Grant
Federal officials on Tuesday announced that the Birmingham Biotechnology Hub, led by Southern Research, had been awarded a $44 million grant from the U.S. Department of Commerce. “Make no mistake, these dollars are a game changer because they will bring new jobs — thousands of jobs — to the city of Birmingham over the next 10 years in the form of biotechnology jobs,
Birmingham secures $44 million in federal Tech Hub grants for AI and biotech projects
The Magic City is poised to become a national leader in biotechnology. Learn about the five groundbreaking projects that will shape Birmingham's future.
EurekAlert!3d
Advanced Science: Insilico Medicine utilized AI technology for novel target discovery and drug repurposing to treat endometriosis
Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...
US imposing new export controls on biotech equipment over China concerns
The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related ...
AI to shape EU health policymaking without new rules
No specific initiatives on AI in healthcare are in sight but the inevitable impact of this technology will guide EU ...
GEN11d
AI Accelerates and Expands Drug Development
By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...
Harvard Business Review12d
Why “Living Intelligence” Is the Next Big Thing
AI is merely one facet of a sweeping technological change underway, and companies that fail to recognize the importance of ...
devdiscourse3d
U.S. Implements New Export Controls on Biotech Over Security Concerns
The U.S. Commerce Department is imposing new export controls on biotechnology equipment due to national security concerns ...
GEN2d
AI-Designed Antivenom Counteracts Toxins from Snakebites in Mice
The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional ...
Here’s Why SoundHound AI, Inc. (SOUN) Is Skyrocketing
We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at ...
Ionis Pharmaceuticals EVP sells $213,889 in stock
Following these transactions, Schneider's direct ownership in Ionis Pharmaceuticals (NASDAQ:IONS) stands at 58,508 shares.